Diarrhea caused by viruses in transplant recipients

Transplant Infectious Disease

Volumn 16, Issue 3, 2014, Pages 347-358

  Lee, L Y ^a   Ison, M G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adenovirus; Cytomegalovirus; Diarrhea; Norovirus; Rotavirus; Solid organ transplantation

Indexed keywords

ANTIVIRUS AGENT;

ADENOVIRUS; ADENOVIRUS INFECTION; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIARRHEA; GRAFT RECIPIENT; HUMAN; MORBIDITY; NOROVIRUS; NOROVIRUS INFECTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; ROTAVIRUS INFECTION; VIROLOGY; PATHOLOGY; TRANSMISSION; VIRUS INFECTION;

DIARRHEA; HUMANS; ORGAN TRANSPLANTATION; VIRUS DISEASES;

EID: 84901980290     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12212     Document Type: Review

References (154)

1. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32 (3): 331-351.
2. Jokinen JJ, Hammainen P, Lemstrom KB, Lommi J, Sipponen J, Harjula AL. Association between gastrointestinal symptoms and health-related quality of life after heart transplantation. J Heart Lung Transplant 2010; 29 (12): 1388-1394.
3. Ekberg H, Kyllonen L, Madsen S, Grave G, Solbu D, Holdaas H. Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients. Transplantation 2007; 83 (3): 282-289.
4. Gil-Vernet S, Amado A, Ortega F, et al. Gastrointestinal complications in renal transplant recipients: MITOS Study. Transplant Proc 2007; 39 (7): 2190-2193.
5. Bunnapradist S, Neri L, Wong W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis 2008; 51 (3): 478-486.
6. Hardinger KL, Brennan DC, Lowell J, Schnitzler MA. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int 2004; 17 (10): 609-616.
7. Roos-Weil D, Ambert-Balay K, Lanternier F, et al. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 2011; 92 (1): 61-69.
8. Maes B, Hadaya K, de Moor B, et al. Severe diarrhea in renal transplant patients: results of the DIDACT study. Am J Transplant 2006; 6 (6): 1466-1472.
9. Arslan H, Inci EK, Azap OK, Karakayali H, Torgay A, Haberal M. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis 2007; 9 (4): 270-275.
10. Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002; 13 (1): 277-287.
11. Krones E, Hogenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 2012; 41 (3): 677-701.
12. Stelzmueller I, Goegele H, Biebl M, et al. Clostridium difficile colitis in solid organ transplantation-a single-center experience. Digest Dis Sci 2007; 52 (11): 3231-3236.
13. Coste JF, Vuiblet V, Moustapha B, et al. Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex PCR assays. J Clin Microbiol 2013; 51 (6): 1841-1849.
14. Altiparmak MR, Trablus S, Pamuk ON, et al. Diarrhoea following renal transplantation. Clin Transplant 2002; 16 (3): 212-216.
15. Fischer SA. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Transplantation 2008; 86 (10): 1327-1339.
16. Ziring D, Tran R, Edelstein S, et al. Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation 2005; 79 (6): 702-709.
17. Kowalsky S, Arnon R, Posada R. Prevention of cytomegalovirus following solid organ transplantation: a literature review. Pediatr Transplant 2013; 17 (6): 499-509.
18. Kotton CN, Kumar D, Caliendo AM, et al. Transplantation Society International CMV Consensus Group. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013; 96 (4): 333-360.
19. Fischer S. Emerging and Rare Viral Infections in Transplantation (3rd edn). Philadelphia, PA: Lippincott Williams & Wilkins, 2010.
20. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 2012; 367 (22): 2126-2132.
21. Farkas T, Jiang X. Rotavirus, Caliciviruses, Astroviruses, Enteric Adenoviruses, and Other Viruses Causing Acute Gastroenteritis (4th edn). Washington, DC: ASM Press, 2009.
22. Collier L, Oxford J. Human Virology (3rd edn). New York: Oxford University Press, 2006.
23. Kroneman A, Vega E, Vennema H, et al. Proposal for a unified norovirus nomenclature and genotyping. Arch Virol 2013; 158 (10): 2059-2068.
24. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology 2006; 346 (2): 312-323.
25. Lindesmith LC, Donaldson EF, Lobue AD, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008; 5 (2): e31.
26. Lindesmith LC, Donaldson EF, Baric RS. Norovirus GII.4 strain antigenic variation. J Virol 2011; 85 (1): 231-242.
27. Nahar S, Afrad MH, Fahmi T, et al. A novel norovirus recombinant strain GII.4/GII.21 in Bangladesh, 2011. Virus Genes 2013; 46 (3): 538-541.
28. Hardy ME. Norovirus protein structure and function. FEMS Microbiol Lett 2005; 253 (1): 1-8.
29. Vinje J, Hamidjaja RA, Sobsey MD. Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. J Virol Methods 2004; 116 (2): 109-117.
30. Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med 2011; 365 (23): 2178-2187.
31. Richardson C, Bargatze RF, Goodwin R, Mendelman PM. Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis. Expert Rev Vaccines 2013; 12 (2): 155-167.
32. Choi JM, Hutson AM, Estes MK, Prasad BV. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Nat Acad Sci USA 2008; 105 (27): 9175-9180.
33. Marionneau S, Ruvoen N, Le Moullac-Vaidye B, et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002; 122 (7): 1967-1977.
34. Tan M, Jiang X. Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol 2011; 19 (8): 382-388.
35. Thorven M, Grahn A, Hedlund KO, et al. A homozygous nonsense mutation (428G->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 2005; 79 (24): 15351-15355.
36. Fankhauser RL, Monroe SS, Noel JS, et al. Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis 2002; 186 (1): 1-7.
37. Patel MM, Hall AJ, Vinje J, Parashar UD. Noroviruses: a comprehensive review. J Clin Virol 2009; 44 (1): 1-8.
38. Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect 2000; 124 (3): 481-487.
39. Teunis PF, Moe CL, Liu P, et al. Norwalk virus: how infectious is it? J Med Virol 2008; 80 (8): 1468-1476.
40. Duizer E, Bijkerk P, Rockx B, De Groot A, Twisk F, Koopmans M. Inactivation of caliciviruses. Appl Environ Microbiol 2004; 70 (8): 4538-4543.
41. Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis 2002; 35 (3): 246-253.
42. Pang XL, Honma S, Nakata S, Vesikari T. Human caliciviruses in acute gastroenteritis of young children in the community. J Infect Dis 2000; 181 (Suppl 2): S288-S294.
43. Gallimore CI, Lewis D, Taylor C, Cant A, Gennery A, Gray JJ. Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH). J Clin Virol 2004; 30 (2): 196-204.
44. Nilsson M, Hedlund KO, Thorhagen M, et al. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol 2003; 77 (24): 13117-13124.
45. Simon A, Schildgen O, Maria Eis-Hubinger A, et al. Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol 2006; 41 (6): 693-699.
46. Florescu DF, Hill LA, McCartan MA, Grant W. Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin. Pediatr Transplant 2008; 12 (3): 372-375.
47. Kaufman SS, Chatterjee NK, Fuschino ME, et al. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant 2003; 3 (6): 764-768.
48. Lee BE, Pang XL, Robinson JL, Bigam D, Monroe SS, Preiksaitis JK. Chronic norovirus and adenovirus infection in a solid organ transplant recipient. Pediatr Infect Dis J 2008; 27 (4): 360-362.
49. Green K. Caliciviridae: The Noroviruses (5th edn). Philadelphia, PA: Lippincott Williams & Wilkins, 2007.
50. Schorn R, Hohne M, Meerbach A, et al. Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution. Clin Infect Dis 2010; 51 (3): 307-314.
51. Chehade H, Girardin E, Delich V, Pascual MA, Venetz JP, Cachat F. Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient. Transpl Infect Dis 2012; 14 (4): E27-E29.
52. Kele B, Lengyel G, Deak J. Comparison of an ELISA and two reverse transcription polymerase chain reaction methods for norovirus detection. Diagn Microbiol Infect Dis 2011; 70 (4): 475-478.
53. Butot S, Le Guyader FS, Krol J, Putallaz T, Amoroso R, Sanchez G. Evaluation of various real-time RT-PCR assays for the detection and quantitation of human norovirus. J Virol Methods 2010; 167 (1): 90-94.
54. Nishimura N, Nakayama H, Yoshizumi S, et al. Detection of noroviruses in fecal specimens by direct RT-PCR without RNA purification. J Virol Methods 2010; 163 (2): 282-286.
55. Atmar RL, Neill FH, Le Guyader FS. Detection of human caliciviruses in fecal samples by rt-PCR. Methods Mol Biol 2011; 665: 39-50.
56. Kageyama T, Kojima S, Shinohara M, et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR. J Clin Microbiol 2003; 41 (4): 1548-1557.
57. Schultz AC, Vega E, Dalsgaard A, et al. Development and evaluation of novel one-step TaqMan realtime RT-PCR assays for the detection and direct genotyping of genogroup I and II noroviruses. J Clin Virol 2011; 50 (3): 230-234.
58. Ishida S, Yoshizumi S, Ikeda T, Miyoshi M, Okano M, Okui T. Sensitive and rapid detection of norovirus using duplex TaqMan reverse transcription-polymerase chain reaction. J Med Virol 2008; 80 (5): 913-920.
59. Wolf S, Williamson WM, Hewitt J, et al. Sensitive multiplex real-time reverse transcription-PCR assay for the detection of human and animal noroviruses in clinical and environmental samples. Appl Environ Microbiol 2007; 73 (17): 5464-5470.
60. Dunbar SA, Zhang H, Tang YW. Advanced techniques for detection and identification of microbial agents of gastroenteritis. Clin Lab Med 2013; 33 (3): 527-552.
61. Dimitriadis A, Bruggink LD, Marshall JA. Evaluation of the Dako IDEIA norovirus EIA assay for detection of norovirus using faecal specimens from Australian gastroenteritis outbreaks. Pathology 2006; 38 (2): 157-165.
62. Costantini V, Grenz L, Fritzinger A, et al. Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus. J Clin Microbiol 2010; 48 (8): 2770-2778.
63. Florescu DF, Hermsen ED, Kwon JY, et al. Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients? Pediatr Transplant 2011; 15 (7): 718-721.
64. Westhoff TH, Vergoulidou M, Loddenkemper C, et al. Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant 2009; 24 (3): 1051-1053.
65. Engelen MA, Gunia S, Stypmann J. Elimination of norovirus in a chronic carrier under immunosuppression after heart transplantation-effect of everolimus. Transplant Int 2011; 24 (11): e102-e103.
66. Boillat Blanco N, Kuonen R, Bellini C, et al. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transpl Infect Dis 2011; 13 (2): 213-215.
67. Ebdrup L, Bottiger B, Molgaard H, Laursen AL. Devastating diarrhoea in a heart-transplanted patient. J Clin Virol 2011; 50 (4): 263-265.
68. Chen Z, Sosnovtsev SV, Bok K, et al. Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis. J Virol 2013; 87 (17): 9547-9557.
69. Rossignol JF, El-Gohary YM. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. Aliment Pharmacol Ther 2006; 24 (10): 1423-1430.
70. Siddiq DM, Koo HL, Adachi JA, Viola GM. Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect 2011; 63 (5): 394-397.
71. Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. The potential economic value of a human norovirus vaccine for the United States. Vaccine 2012; 30 (49): 7097-7104.
72. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009; 361 (18): 1776-1785.
73. Sandora TJ, Shih MC, Goldmann DA. Reducing absenteeism from gastrointestinal and respiratory illness in elementary school students: a randomized, controlled trial of an infection-control intervention. Pediatrics 2008; 121 (6): e1555-e1562.
74. Xerry J, Gallimore CI, Cubitt D, Gray JJ. Tracking environmental norovirus contamination in a pediatric primary immunodeficiency unit. J Clin Microbiol 2010; 48 (7): 2552-2556.
75. Belliot G, Lavaux A, Souihel D, Agnello D, Pothier P. Use of murine norovirus as a surrogate to evaluate resistance of human norovirus to disinfectants. Appl Environ Microbiol 2008; 74 (10): 3315-3318.
76. CDC. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep 2011; 60 (RR-3): 1-18.
77. Kampf G, Grotheer D, Steinmann J. Efficacy of three ethanol-based hand rubs against feline calicivirus, a surrogate virus for norovirus. J Hosp Infect 2005; 60 (2): 144-149.
78. Liu P, Yuen Y, Hsiao HM, Jaykus LA, Moe C. Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol 2010; 76 (2): 394-399.
79. Arias A, Emmott E, Vashist S, Goodfellow I. Progress towards the prevention and treatment of norovirus infections. Future Microbiol 2013; 8: 1475-1487.
80. Lopman B, Gastanaduy P, Park GW, Hall AJ, Parashar UD, Vinje J. Environmental transmission of norovirus gastroenteritis. Curr Opin Virol 2012; 2 (1): 96-102.
81. MacCannell T, Umscheid CA, Agarwal RK, Lee I, Kuntz G, Stevenson KB. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol 2011; 32 (10): 939-969.
82. Chen SC, Tan LB, Huang LM, Chen KT. Rotavirus infection and the current status of rotavirus vaccines. J Formos Med Assoc 2012; 111 (4): 183-193.
83. Patton JT. Rotavirus diversity and evolution in the post-vaccine world. Discov Med 2012; 13 (68): 85-97.
84. Hoshino Y, Kapikian AZ. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development. J Health Pop Nutr 2000; 18 (1): 5-14.
85. Lorrot M, Vasseur M. How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virol J 2007; 4: 31.
86. Dennehy PH. Rotavirus infection: an update on management and prevention. Adv Pediatr 2012; 59 (1): 47-74.
87. Stelzmueller I, Biebl M, Graziadei I, Wiesmayr S, Margreiter R, Bonatti H. Regarding diarrhea in liver transplant recipients: etiology and management. Liver Transpl 2006; 12 (1): 163-164.
88. Chandran A, Fitzwater S, Zhen A, Santosham M. Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics 2010; 4: 213-229.
89. Stelzmueller I, Wiesmayr S, Swenson BR, et al. Rotavirus enteritis in solid organ transplant recipients: an underestimated problem? Transpl Infect Dis 2007; 9 (4): 281-285.
90. Stelzmueller I, Dunst KM, Hengster P, et al. A cluster of rotavirus enteritis in adult transplant recipients. Transplant Int 2005; 18 (4): 470-474.
91. Adeyi OA, Costa G, Abu-Elmagd KM, Wu T. Rotavirus infection in adult small intestine allografts: a clinicopathological study of a cohort of 23 patients. Am J Transplant 2010; 10 (12): 2683-2689.
92. Giovanelli M, Gupte GL, Sharif K, Mayer DA, Mirza DF. Chronic rejection after combined liver and small bowel transplantation in a child with chronic intestinal pseudo-obstruction: a case report. Transplant Proc 2008; 40 (5): 1763-1767.
93. Bernstein DI. Rotavirus overview. Pediatr Infect Dis J 2009; 28 (3 Suppl): S50-S53.
94. Cicek C, Karatas T, Altuglu I, Koturoglu G, Kurugol Z, Bilgic A. Comparison of ELISA with shell vial cell culture method for the detection of human rotavirus in fecal specimens. New Microbiol 2007; 30 (2): 113-118.
95. Wilhelmi I, Colomina J, Martin-Rodrigo D, Roman E, Sanchez-Fauquier A. New immunochromatographic method for rapid detection of rotaviruses in stool samples compared with standard enzyme immunoassay and latex agglutination techniques. Euro J Clin Microbiol Infect Dis 2001; 20 (10): 741-743.
96. Nilsson M, Svenungsson B, Hedlund KO, et al. Incidence and genetic diversity of group C rotavirus among adults. J Infect Dis 2000; 182 (3): 678-684.
97. Yee EL, Jiang B, Kendall RS, Humphrey C, Glass RI. Group C rotavirus in a pediatric kidney transplant patient with diarrhea. J Clin Virol 2006; 36 (4): 306-308.
98. Husain M, Seth P, Broor S. Detection of group A rotavirus by reverse transcriptase and polymerase chain reaction in feces from children with acute gastroenteritis. Arch Virol 1995; 140 (7): 1225-1233.
99. Zerr DM, Allpress AL, Heath J, Bornemann R, Bennett E. Decreasing hospital-associated rotavirus infection: a multidisciplinary hand hygiene campaign in a children's hospital. Pediatr Infect Dis J 2005; 24 (5): 397-403.
100. Fischer TK, Steinsland H, Valentiner-Branth P. Rotavirus particles can survive storage in ambient tropical temperatures for more than 2 months. J Clin Microbiol 2002; 40 (12): 4763-4764.
101. Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30 (1 Suppl): S30-S34.
102. Cortes JE, Curns AT, Tate JE, et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365 (12): 1108-1117.
103. Tate JE, Haynes A, Payne DC, et al. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000-2012. Pediatr Infect Dis J 2013; 32 (7): 741-744.
104. Danziger-Isakov L, Kumar D. Vaccination in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 311-317.
105. Ison MG, Green M. Adenovirus in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S161-S165.
106. Echavarria M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 2008; 21 (4): 704-715.
107. Berk A. Adenoviridae: The Viruses and Their Replication (5th edn). Philadelphia, PA: Lippincott Williams & Wilkins, 2007.
108. Wold W, Horwitz M. Adenoviruses (5th edn). Philadelphia, PA: Lippincott Williams & Wilkins, 2007.
109. Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43 (3): 331-339.
110. Van R, Wun CC, O'Ryan ML, Matson DO, Jackson L, Pickering LK. Outbreaks of human enteric adenovirus types 40 and 41 in Houston day care centers. J Pediatr 1992; 120 (4 Pt 1): 516-521.
111. Koneru B, Atchison R, Jaffe R, Cassavilla A, Van Thiel DH, Starzl TE. Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc 1990; 22 (4): 1547-1548.
112. Hoffman JA. Adenovirus infections in solid organ transplant recipients. Curr Opin Organ Transplant 2009; 14 (6): 625-633.
113. Pinchoff RJ, Kaufman SS, Magid MS, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003; 76 (1): 183-189.
114. Michaels MG, Green M, Wald ER, Starzl TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992; 165 (1): 170-174.
115. McLaughlin GE, Delis S, Kashimawo L, et al. Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR. Am J Transplant 2003; 3 (2): 224-228.
116. Florescu DF, Hoffman JA. Adenovirus in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 206-211.
117. Florescu DF, Islam MK, Mercer DF, et al. Adenovirus infections in pediatric small bowel transplant recipients. Transplantation 2010; 90 (2): 198-204.
118. Berho M, Torroella M, Viciana A, et al. Adenovirus enterocolitis in human small bowel transplants. Pediatr Transplant 1998; 2 (4): 277-282.
119. Matthes-Martin S, Feuchtinger T, Shaw PJ, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis 2012; 14 (6): 555-563.
120. Damen M, Minnaar R, Glasius P, et al. Real-time PCR with an internal control for detection of all known human adenovirus serotypes. J Clin Microbiol 2008; 46 (12): 3997-4003.
121. Pehler-Harrington K, Khanna M, Waters CR, Henrickson KJ. Rapid detection and identification of human adenovirus species by adenoplex, a multiplex PCR-enzyme hybridization assay. J Clin Microbiol 2004; 42 (9): 4072-4076.
122. Gleaves CA, Militoni J, Ashley RL. An enzyme immunoassay for the direct detection of adenovirus in clinical specimens. Diagn Microbiol Infect Dis 1993; 17 (1): 57-59.
123. Buckwalter SP, Teo R, Espy MJ, Sloan LM, Smith TF, Pritt BS. Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources. J Clin Microbiol 2012; 50 (3): 766-771.
124. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35 (10 Suppl 2): S65-S164.
125. Rutala WA, Peacock JE, Gergen MF, Sobsey MD, Weber DJ. Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrobial Agents Chemother 2006; 50 (4): 1419-1424.
126. Sanghavi S, Rowe D, Rinaldo C. Cytomegalovirus, Varicella-Zoster Virus, and Epstein-Barr Virus (4th edn). Washington, DC: ASM Press, 2009.
127. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43 (9): 1143-1151.
128. Razonable RR, Limaye AP. Cytomegalovirus Infection after Solid Organ Transplantation (3rd edn). Philadelphia, PA: Lippincott Williams & Wilkins, 2010.
129. Razonable RR, Rivero A, Rodriguez A, et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001; 184 (11): 1461-1464.
130. Munksgaard B. Cytomegalovirus. Am J Transplant 2004; 4: 51-58.
131. Pavlopoulou ID, Syriopoulou VP, Chelioti H, et al. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients. Clin Microbiol Infect 2005; 11 (9): 736-743.
132. Arthurs SK, Eid AJ, Pedersen RA, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008; 46 (6): 840-846.
133. Lemonovich TL, Watkins RR. Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients. Curr Infect Dis Rep 2012; 14 (1): 33-40.
134. Buckner FS, Pomeroy C. Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 1993; 17 (4): 644-656.
135. Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs 2010; 70 (8): 965-981.
136. Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89 (7): 779-795.
137. Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol 2002; 40 (3): 746-752.
138. Razonable RR. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients. Infect Dis Clin North Am 2013; 27 (2): 317-342.
139. Durand CM, Marr KA, Arnold CA, et al. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin Infect Dis 2013; 57 (11): 1550-1559.
140. Razonable RR, Humar A. Cytomegalovirus in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 93-106.
141. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev 2013; 26 (4): 703-727.
142. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34 (8): 1094-1097.
143. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119 (9): 924-935.
144. Asberg A, Humar A, Rollag H, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007; 7 (9): 2106-2113.
145. Sawyer MD, Mayoral JL, Gillingham KJ, Kramer MA, Dunn DL. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch Surg 1993; 128 (2): 165-169; discussion 170.
146. Pilmore H, Collins J, Dittmer I, et al. Fatal human herpesvirus-6 infection after renal transplantation. Transplantation 2009; 88 (6): 762-765.
147. Deborska-Materkowska D, Sadowska A, Matlosz B, Zegarska J, Durlik M. [Human herpes virus 6 infection in renal transplant recipient - case report]. Przegl Epidemiol 2006; 60 (1): 141-146.
148. Waggoner JJ, Soda EA, Deresinski S. Rare and emerging viral infections in transplant recipients. Clin Infect Dis 2013; 57 (8): 1182-1188.
149. Fischer SA, Graham MB, Kuehnert MJ, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354 (21): 2235-2249.
150. Shitrit D, Shitrit AB, Dickman R, Sahar G, Saute M, Kramer MR. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case. Dis Colon Rectum 2005; 48 (11): 2144-2147.
151. Hranjec T, Bonatti H, Roman AL, et al. Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report. Transplant Proc 2008; 40 (5): 1780-1782.
152. Campanini G, Rovida F, Meloni F, et al. Persistent human cosavirus infection in lung transplant recipient, Italy. Emerg Infect Dis 2013; 19 (10): 1667-1669.
153. de Vries JJ, Bredius RG, van Rheenen PF, et al. Human bocavirus in an immunocompromised child presenting with severe diarrhea. J Clin Microbiol 2009; 47 (4): 1241-1243.
154. Jamieson FB, Wang EE, Bain C, Good J, Duckmanton L, Petric M. Human torovirus: a new nosocomial gastrointestinal pathogen. J Infect Dis 1998; 178 (5): 1263-1269.